Showing results (601-610 of 1,191) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|March 17, 2012
Adaptive blinded sample size adjustment for comparing two normal means--a mostly Bayesian approachAndrew M HartleyPharmaceutical Statistics|September 20, 2007
Combining p-values in large-scale genomics experimentsDmitri V Zaykin, Lev A Zhivotovsky, Wendy Czika, et al.Pharmaceutical Statistics|July 22, 2008
Evaluation of a sequential global test of improved recovery following stroke as applied to the ICTUS trial of citicolineKim Bolland, John Whitehead, Erik Cobo, et al.Pharmaceutical Statistics|February 7, 2022
Incorporating historical controls in clinical trials with longitudinal outcomes using the modified power priorHongchao Qi, Dimitris Rizopoulos, Emmanuel Lesaffre, et al.Pharmaceutical Statistics|February 22, 2022
Utilizing restricted mean duration of response for efficacy evaluation of cancer treatmentsBo Huang, Lu TianPharmaceutical Statistics|September 29, 2021
Extending the two-stage single arm phase II clinical trial design to the delayed response scenarioBo Chen, Xing Zhao, Juying ZhangPharmaceutical Statistics|March 17, 2022
Assessment of pharmacokinetic linearity after repeated drug administrationAlexander Bauer, Matts Kagedal, Martin J WolfseggerPharmaceutical Statistics|March 24, 2022
A two-stage adaptive clinical trial design with data-driven subgroup identification at interim analysisSarah E Johnston, Ilya Lipkovich, Alex Dmitrienko, et al.Pharmaceutical Statistics|March 25, 2022
SCI: A Bayesian adaptive phase I/II dose-finding design accounting for semi-competing risks outcomes for immunotherapy trialsYifei Zhang, Beibei Guo, Sha Cao, et al.Pharmaceutical Statistics|February 24, 2022
Pairwise joint modeling of clustered and high-dimensional outcomes with covariate missingness in pediatric pneumonia careSusan Gachau, Edmund Njeru Njagi, Geert Molenberghs, et al.Pageof 120